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Ovarian cancer is the secondmost common gynecologic malignancy
and the most common cause of death among women with gynecologic
cancer. Epithelial ovarian cancer is historically known as the “silent
killer” due to symptoms that would not occur until very late in the
course of the disease. Advanced ovarian cancer typically presents with
abdominal distention, nausea, anorexia, or early satiety due to the
presence of ascites and omental or bowel metastases. Dyspnea can
occasionally be present due to a pleural effusion. The main route of
dissemination in ovarian cancer is through a transcoelemic or lymphatic
spread. Hematogenous spread is uncommon for this disease.
Ovarian cancer with bone metastasis is a relatively rare occur-
rence. Rose et al. in an autopsy study showed that metastasis to
bones from these tumors is rare (0.1–0.12%). This and other case
reports have shown that when bone metastases occur they often
appear as recurrent disease or in conjunction with other abdominal
metastases (Rose et al., 1989; Cormio et al., 2003). Other case reports
have described ovarian cancer presenting initially with bone metasta-
ses prior to primary staging. These cases, however, had clinically
signiﬁcant abdominal or pelvic disease existing simultaneously that
did not cause symptoms (Dvoretsky et al., 1989; Chen et al., 2009).
Bony metastases existing on initial presentation in the absence of
signiﬁcant abdominal disease has not been observed thus far to our
knowledge.⁎ Corresponding author.
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A 47 year-old, G4P2022, with a prior total abdominal hysterecto-
my for leiomyomatous uterus, presented with back pain over her
right rib cage. There were no associated abdominal complaints. Mag-
netic resonance imaging of the thoracic spine revealed a mass at T10
with abnormal enhancement that extended from the vertebral body
and the posterior elements, into the 10th rib — concerning for neo-
plastic involvement (Picture 1). Para-spinal core biopsy of the lesion
was positive for adenocarcinoma with immunohistochemical stains
positive for CK7 and WT-1. Staining for CK20, TTF-1 and CEA were
all negative. This was compatible with a high-grade serous carcinoma
of the gynecologic tract. The patient was promptly referred to gyne-
cologic oncology for evaluation. She underwent a bilateral salpingo-
oophorectomy, appendectomy, and omental sampling. A normal
upper abdominal survey was noted intra-operatively. The ovaries
themselves were grossly normal. The histopathologic report was
positive only for a 3 mm micro-foci of serous carcinoma on the left
ovarian surface, staining positive for WT-1 and p53 — similar to her
known focus of carcinoma from her para-spinal core biopsy. The
omentum, appendix, and pelvic washings were all negative for malig-
nant cells. The patient was diagnosed with Stage IVB serous ovarian
carcinoma with no identiﬁable involvement other than the thoracic
vertebral lesion and small foci of malignant tissue on the left ovary.
The patient's CA-125 level was 56.6 U/ml.
The patient was referred to the spinal oncology service for resection
of the vertebral mass. She underwent an intralesional en-bloc resection
of the tumor, using a posterior costotransversectomy approach. To ob-
tain adequate margins three ribs were removed as well as portions
of her parietal pleura. A chest wall reconstruction was performed
using a Gore-tex graft. A posterior spinal fusion and decompression
from T8–T12 was performed with instrumentation. Surgical pathol-
ogy revealed high-grade serous adenocarcinoma at the T10 level
(Picture 2). Rib and pleural tissue were all negative for malignant
cells. The histology was consistent with pathology from the gyneco-
logic tract. The patient's post-operative recovery was complicated by
a right hemothorax, requiring 2 chest tube placements, prolonging
her hospital stay; this complication resolved leading to a full surgical
recovery. Post-operatively the patient underwent an adjuvant
course of carboplatin/paclitaxel along with stereotactic radiation
(8 Gy×3) to the spine. At the time of the drafting of this manuscript,
the patient has completed her adjuvant chemotherapy regiment.
She is disease free as demonstrated by her post-operative MRI
Picture 1. Sagittal MRI image of T10 metastatic lesion.
Picture 3. Post-operative MRI.
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clinical evidence of disease.
Discussion
Ovarian epithelial malignancies usually spread by direct extension,
trans-peritoneal seeding or lymphatic spread. Distant metastases are
present in only 8% of the patients at the time of their diagnosis.
Twenty-two percent of patients present with distant metastases during
the course of the disease (Cormio et al., 2003). Bone metastases from
epithelial ovarian malignancies have rarely been reported in the litera-
ture. Rose et al. in their autopsy series reviewed the metastatic pattern
in 428 ovarian cancers and correlated different histologic sub-types
with patterns of spread. The incidence of bony metastasis was 0.06–
0.19% for epithelial histology, highlighting the rarity of bone involve-
ment in this form of malignancy (Rose et al., 1989). Themode of spread
appears to be hematogenous although no deﬁnitive route of spread has
been deﬁned.
In an autopsy series, Dauplat et al. analyzed 336 patients of distant
metastasis from ovarian cancers. Four patients had bony metastases,
2 of which were present in the thoracic vertebra. None of the patients
in this series had bone metastasis as a ﬁrst site of presentation.
According to the authors, bony metastases are the rarest known
ﬁrst site for metastatic disease with a median time for development
ranging from 13 to 49 months (Dvoretsky et al., 1989). The vertebral
bodies are the most common sites for metastasis, followed by the ribs,
clavicle, skull and femur.Picture 2. Resection of T10 mass along with section of rib. Histopathology revealed
high grade serous carcinoma of ovarian origin.When bonymetastases do occur they are rarely isolated ﬁndings. In
situations where there are isolated ﬁndings they are generally present
as recurrent disease in previously staged patients (Gottwald et al.,
2012). Tiwari et al. reported a case of ovarian cancer metastasizing to
the lumbar vertebrae (Tiwari et al., 2007). The lumbar metastasis in
this case happened in conjunction with hepatic lesions, as a recurrent
presentation in a patient that had previously been diagnosed with
stage IIIC ovarian carcinoma. Chen et al. also reported a case of back
pain from vertebral metastasis presenting as the initial complaint in a
patient with ovarian adenosarcoma (Chen et al., 2009). However, in
this patient signiﬁcant abdominal diseasewas noted on surgical staging.
Kingston et al. also reported on a patient who presented with right
shoulder pain from an ovarian metastasis to the humeral head but
further work up revealed signiﬁcant abdominal and thoracic pathology
as well (Kingston et al., 2001). Bone involvement in ovarian cancer is
associated with a poor prognosis. Kumar et al. reported a median
survival of 7.5 months (range 6–39 months) in patients with bony
involvement (Kumar et al., 1992). The use of direct surgical resection
plus post-operative radiotherapy has been shown to be superior to
radiotherapy alone in patients with spinal metastases (Patchell et al.,
2005).
In the present case, we report a patient with an initial presentation
of back pain from vertebral metastasis that lacked any gross disease
in her pelvis or abdomen during her staging procedure. This is an
extremely rare method for ovarian cancer to initially present and, as
far as we know, has never been reported.Conﬂict of interest statement
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